Clare J. Twist

Publications

• Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. Liedtke M, Twist CJ, Medeiros BC, Gotlib JR, Berube C, Bieber MM, Bhat NM, Teng NN, Coutre SE. Haematologica. 2012; 97 (1): 30-7
• Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study. Gorman MF, Ji L, Ko RH, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML. Pediatr Blood Cancer. 2010; 55 (3): 421-9
• Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML. J Clin Oncol. 2010; 28 (4): 648-54
• Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin. Krishnan C, Twist CJ, Fu T, Arber DA. Am J Clin Pathol. 2009; 131 (1): 49-57
• 123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. Iagaru A, Peterson D, Quon A, Dutta S, Twist C, Daghighian F, Gambhir SS, Albanese C. Mol Imaging Biol. 2008 Jan-Feb; 10 (1): 19-23
• Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis. O'Brien MM, Lee-Kim Y, George TI, McClain KL, Twist CJ, Jeng M. Pediatr Blood Cancer. 2008; 50 (2): 381-3
• Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro. Bieber MM, Twist CJ, Bhat NM, Teng NN. Pediatr Blood Cancer. 2007; 48 (4): 380-6
• A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM. Clin Cancer Res. 2006; 12 (6): 1750-9
• The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B. Cancer Lett. 2005; 228 (1-2): 257-66
• Assessment of lymphadenopathy in children. Twist CJ, Link MP. Pediatr Clin North Am. 2002; 49 (5): 1009-25
• A case from Stanford University. Neuroblastoma with diffuse bone marrow involvement. Durski JM, Twist CJ, Goris M. Nucl Med Rev Cent East Eur. 2001; 4 (1): 61-2
• The mouse Cd83 gene: structure, domain organization, and chromosome localization. Twist CJ, Beier DR, Disteche CM, Edelhoff S, Tedder TF. Immunogenetics. 1998 Nov-Dec; 48 (6): 383-93
• Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF, deAlarcon PA, Twist C, Nachman JB, Hale GA, Harris RE, Rozans MK, Kurtzberg J, Grayson GH, Williams TE, Lenarsky C, Wagner JE, Krivit W. Blood. 1998; 91 (7): 2601-8
• Isolation of mouse T-cell lymphoma lines from different long-term interleukin 2-dependent cultures. Giglia JS, Ovak GM, Yoshida MA, Twist CJ, Jeffery AR, Pauly JL. Cancer Res. 1985; 45 (10): 5027-34
• Studies of cultured human T lymphocytes. II. Initiation of paired T- and B-cell lines from healthy donors. Pauly J, Russell CW, Pirela DL, Twist CJ, Reinertson R, Callahan J, Minowada J. Proc Soc Exp Biol Med. 1983; 172 (3): 283-90